No headlines found.
Cibus Reports Fourth Quarter Financial Results and Provides Business Update
Globe Newswire (Thu, 21-Mar 4:05 PM ET)
Cibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Globe Newswire (Tue, 19-Mar 8:30 AM ET)
Cibus to Participate in the 36th Annual Roth Conference
Globe Newswire (Wed, 13-Mar 7:35 AM ET)
Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call
Globe Newswire (Thu, 7-Mar 7:00 AM ET)
Cibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the US
Globe Newswire (Mon, 26-Feb 7:00 AM ET)
European Parliament Votes to Support Proposal for the Regulation of New Genomic Techniques
Globe Newswire (Wed, 7-Feb 12:51 PM ET)
Globe Newswire (Thu, 25-Jan 4:30 PM ET)
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Cibus - Class A trades on the NASDAQ stock market under the symbol CBUS.
As of April 18, 2024, CBUS stock price climbed to $15.72 with 101,493 million shares trading.
CBUS has a beta of 1.19, meaning it tends to be more sensitive to market movements. CBUS has a correlation of 0.01 to the broad based SPY ETF.
CBUS has a market cap of $329.95 million. This is considered a Small Cap stock.
Last quarter Cibus - Class A reported $1 million in Revenue and -$1.27 earnings per share. This beat revenue expectation by $723,000 and exceeded earnings estimates by $.16.
The top ETF exchange traded funds that CBUS belongs to (by Net Assets): VTI, VXF.
CBUS support price is $14.66 and resistance is $16.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CBUS stock will trade within this expected range on the day.